RecruitingNCT06682923

MolecuLightDX Measurement Feature Clinical Validation

Evaluation of the MolecuLightDX Device in the Measurement of Surface Wounds in Patients

Sponsor

MolecuLight Inc.

Enrollment

72 participants

Start Date

Oct 23, 2024

Study Type

OBSERVATIONAL

Conditions

Wounds Wound of Skin

Summary

This is a prospective, single-arm, paired clinical evaluation of the MolecuLightDX device in the measurement of surface wounds in patients.

Eligibility

Min Age: 22 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying MolecuLight DX Imaging Device for people with wound of skin and wounds. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 22 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEMolecuLight DX Imaging Device

The MolecuLight DX Imaging Device is a fluorescence imaging device intended to acquire images from wounds. This will not alter the participant's standard of care treatment.